Log in to save to my catalogue

Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential

Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5680162

Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential

About this item

Full title

Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential

Publisher

London: Nature Publishing Group UK

Journal title

Molecular psychiatry, 2018-08, Vol.23 (8), p.1745-1755

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Development of an efficacious, non-addicting analgesic has been challenging. Discovery of novel mechanisms underlying addiction may present a solution. Here we target the neurokinin system, which is involved in both pain and addiction. Morphine exerts its rewarding actions, at least in part, by inhibiting GABAergic input onto substance P (SP) neuro...

Alternative Titles

Full title

Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5680162

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5680162

Other Identifiers

ISSN

1359-4184,1476-5578

E-ISSN

1476-5578

DOI

10.1038/mp.2017.102

How to access this item